Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas

We report genetic aberrations that activate the ERK/MAP kinase pathway in 100% of posterior fossa pilocytic astrocytomas, with a high frequency of gene fusions between KIAA1549 and BRAF among these tumours. These fusions were identified from analysis of focal copy number gains at 7q34, detected usin...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pathology Vol. 218; no. 2; pp. 172 - 181
Main Authors: Forshew, Tim, Tatevossian, Ruth G, Lawson, Andrew RJ, Ma, Jing, Neale, Geoff, Ogunkolade, Babatunji W, Jones, Tania A, Aarum, Johan, Dalton, James, Bailey, Simon, Chaplin, Tracy, Carter, Rowena L, Gajjar, Amar, Broniscer, Alberto, Young, Bryan D, Ellison, David W, Sheer, Denise
Format: Journal Article
Language:English
Published: Chichester, UK John Wiley & Sons, Ltd 01-06-2009
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report genetic aberrations that activate the ERK/MAP kinase pathway in 100% of posterior fossa pilocytic astrocytomas, with a high frequency of gene fusions between KIAA1549 and BRAF among these tumours. These fusions were identified from analysis of focal copy number gains at 7q34, detected using Affymetrix 250K and 6.0 SNP arrays. PCR and sequencing confirmed the presence of five KIAA1549–BRAF fusion variants, along with a single fusion between SRGAP3 and RAF1. The resulting fusion genes lack the auto‐inhibitory domains of BRAF and RAF1, which are replaced in‐frame by the beginning of KIAA1549 and SRGAP3, respectively, conferring constitutive kinase activity. An activating mutation of KRAS was identified in the single pilocytic astrocytoma without a BRAF or RAF1 fusion. Further fusions and activating mutations in BRAF were identified in 28% of grade II astrocytomas, highlighting the importance of the ERK/MAP kinase pathway in the development of paediatric low‐grade gliomas. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Bibliography:Samantha Dickson Brain Tumour Trust
istex:1880275B67332C71E335B497D11D070D82EECF69
Cancer Research UK Programme - No. C5321/A8318
ark:/67375/WNG-J14BRKG8-9
Cancer Research UK London Research Institute
Supporting Information
No conflicts of interest were declared.
ArticleID:PATH2558
These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0022-3417
1096-9896
DOI:10.1002/path.2558